Index of /wp-content/uploads/2023/04
| Name | Last modified | Size | Description |
|
| Parent Directory | | - | |
| Danyelza (Generic Na..> | 2023-04-04 22:25 | 1.5K | |
| Danyelza (Generic Na..> | 2023-04-04 22:20 | 866 | |
| Danyelza (Generic Na..> | 2023-04-04 22:25 | 2.8K | |
| Danyelza (Generic Na..> | 2023-04-04 22:20 | 1.6K | |
| Danyelza (Generic Na..> | 2023-04-04 22:25 | 7.6K | |
| Danyelza (Generic Na..> | 2023-04-04 22:20 | 4.5K | |
| Danyelza (Generic Na..> | 2023-04-04 22:25 | 15K | |
| Danyelza (Generic Na..> | 2023-04-04 22:20 | 9.9K | |
| Daprodustat-100x100.jpg | 2023-04-04 05:47 | 3.5K | |
| Daprodustat-100x100...> | 2023-04-04 05:42 | 2.8K | |
| Daprodustat-150x77.jpg | 2023-04-04 05:47 | 3.9K | |
| Daprodustat-150x77.j..> | 2023-04-04 05:42 | 3.0K | |
| Daprodustat-300x153.jpg | 2023-04-04 05:47 | 13K | |
| Daprodustat-300x153...> | 2023-04-04 05:42 | 9.8K | |
| Daprodustat-300x300.jpg | 2023-04-04 05:47 | 19K | |
| Daprodustat-300x300...> | 2023-04-04 05:42 | 15K | |
| Daprodustat.jpg | 2023-04-04 05:47 | 37K | |
| Daprodustat.jpg.webp | 2023-04-04 05:42 | 26K | |
| Daratumumab and Hyal..> | 2023-04-04 22:53 | 1.8K | |
| Daratumumab and Hyal..> | 2023-04-04 22:48 | 1.1K | |
| Daratumumab and Hyal..> | 2023-04-04 22:53 | 3.3K | |
| Daratumumab and Hyal..> | 2023-04-04 22:48 | 2.2K | |
| Daratumumab and Hyal..> | 2023-04-04 22:53 | 10K | |
| Daratumumab and Hyal..> | 2023-04-04 22:48 | 7.2K | |
| Daratumumab and Hyal..> | 2023-04-04 22:53 | 24K | |
| Daratumumab and Hyal..> | 2023-04-04 22:48 | 17K | |
| Daridorexant-100x100..> | 2023-04-04 23:17 | 2.0K | |
| Daridorexant-100x100..> | 2023-04-04 23:17 | 1.1K | |
| Daridorexant-150x100..> | 2023-04-04 23:17 | 2.2K | |
| Daridorexant-150x100..> | 2023-04-04 23:17 | 1.1K | |
| Daridorexant-300x201..> | 2023-04-04 23:17 | 6.2K | |
| Daridorexant-300x201..> | 2023-04-04 23:17 | 3.4K | |
| Daridorexant-300x300..> | 2023-04-04 23:17 | 10K | |
| Daridorexant-300x300..> | 2023-04-04 23:17 | 5.7K | |
| Daridorexant-e168067..> | 2023-04-04 23:22 | 2.0K | |
| Daridorexant-e168067..> | 2023-04-04 23:17 | 1.3K | |
| Daridorexant-e168067..> | 2023-04-04 23:22 | 2.6K | |
| Daridorexant-e168067..> | 2023-04-04 23:17 | 1.6K | |
| Daridorexant-e168067..> | 2023-04-04 23:22 | 7.4K | |
| Daridorexant-e168067..> | 2023-04-04 23:17 | 4.6K | |
| Daridorexant-e168067..> | 2023-04-04 23:22 | 9.6K | |
| Daridorexant-e168067..> | 2023-04-04 23:17 | 5.9K | |
| Daridorexant-e168067..> | 2023-04-04 23:22 | 16K | |
| Daridorexant-e168067..> | 2023-04-04 23:17 | 9.9K | |
| Daridorexant.jpg | 2023-04-04 23:17 | 18K | |
| Daridorexant.jpg.webp | 2023-04-04 23:17 | 10K | |
| Darolutamide-100x100..> | 2023-04-04 23:43 | 2.1K | |
| Darolutamide-100x100..> | 2023-04-04 23:38 | 1.3K | |
| Darolutamide-150x150..> | 2023-04-04 23:43 | 3.5K | |
| Darolutamide-150x150..> | 2023-04-04 23:38 | 2.2K | |
| Darolutamide-300x300..> | 2023-04-04 23:43 | 9.9K | |
| Darolutamide-300x300..> | 2023-04-04 23:38 | 6.0K | |
| Darolutamide.jpg | 2023-04-04 23:43 | 22K | |
| Darolutamide.jpg.webp | 2023-04-04 23:38 | 14K | |
| Darunavir, Cobicista..> | 2023-04-05 00:35 | 2.8K | |
| Darunavir, Cobicista..> | 2023-04-05 00:35 | 1.5K | |
| Darunavir, Cobicista..> | 2023-04-05 00:35 | 3.0K | |
| Darunavir, Cobicista..> | 2023-04-05 00:35 | 1.7K | |
| Darunavir, Cobicista..> | 2023-04-05 00:35 | 8.9K | |
| Darunavir, Cobicista..> | 2023-04-05 00:35 | 4.8K | |
| Darunavir, Cobicista..> | 2023-04-05 00:35 | 17K | |
| Darunavir, Cobicista..> | 2023-04-05 00:35 | 9.4K | |
| Darunavir, Cobicista..> | 2023-04-05 00:42 | 2.6K | |
| Darunavir, Cobicista..> | 2023-04-05 00:35 | 1.8K | |
| Darunavir, Cobicista..> | 2023-04-05 00:42 | 4.2K | |
| Darunavir, Cobicista..> | 2023-04-05 00:35 | 2.8K | |
| Darunavir, Cobicista..> | 2023-04-05 00:42 | 13K | |
| Darunavir, Cobicista..> | 2023-04-05 00:35 | 7.7K | |
| Darunavir, Cobicista..> | 2023-04-05 00:42 | 15K | |
| Darunavir, Cobicista..> | 2023-04-05 00:35 | 9.5K | |
| Darunavir, Cobicista..> | 2023-04-05 00:42 | 22K | |
| Darunavir, Cobicista..> | 2023-04-05 00:35 | 14K | |
| Darunavir, Cobicista..> | 2023-04-05 00:35 | 29K | |
| Darunavir, Cobicista..> | 2023-04-05 00:35 | 14K | |
| Darunavir and Cobici..> | 2023-04-05 00:32 | 2.5K | |
| Darunavir and Cobici..> | 2023-04-05 00:29 | 1.6K | |
| Darunavir and Cobici..> | 2023-04-05 00:32 | 6.6K | |
| Darunavir and Cobici..> | 2023-04-05 00:27 | 4.9K | |
| Darunavir and Cobici..> | 2023-04-05 00:32 | 3.5K | |
| Darunavir and Cobici..> | 2023-04-05 00:29 | 2.2K | |
| Darunavir and Cobici..> | 2023-04-05 00:32 | 8.7K | |
| Darunavir and Cobici..> | 2023-04-05 00:27 | 6.5K | |
| Darunavir and Cobici..> | 2023-04-05 00:32 | 9.6K | |
| Darunavir and Cobici..> | 2023-04-05 00:29 | 6.1K | |
| Darunavir and Cobici..> | 2023-04-05 00:32 | 31K | |
| Darunavir and Cobici..> | 2023-04-05 00:27 | 23K | |
| Darunavir and Cobici..> | 2023-04-05 00:32 | 12K | |
| Darunavir and Cobici..> | 2023-04-05 00:29 | 7.9K | |
| Darunavir and Cobici..> | 2023-04-05 00:32 | 48K | |
| Darunavir and Cobici..> | 2023-04-05 00:27 | 37K | |
| Darunavir and Cobici..> | 2023-04-05 00:32 | 18K | |
| Darunavir and Cobici..> | 2023-04-05 00:29 | 13K | |
| Darunavir and Cobici..> | 2023-04-05 00:32 | 96K | |
| Darunavir and Cobici..> | 2023-04-05 00:27 | 75K | |
| Dasiglucagon Injecti..> | 2023-04-05 01:46 | 1.9K | |
| Dasiglucagon Injecti..> | 2023-04-05 01:41 | 1.0K | |
| Dasiglucagon Injecti..> | 2023-04-05 01:46 | 2.4K | |
| Dasiglucagon Injecti..> | 2023-04-05 01:41 | 1.2K | |
| Dasiglucagon Injecti..> | 2023-04-05 01:46 | 6.6K | |
| Dasiglucagon Injecti..> | 2023-04-05 01:41 | 3.3K | |
| Dasiglucagon Injecti..> | 2023-04-05 01:46 | 9.6K | |
| Dasiglucagon Injecti..> | 2023-04-05 01:41 | 5.3K | |
| Dasiglucagon Injecti..> | 2023-04-05 01:46 | 12K | |
| Dasiglucagon Injecti..> | 2023-04-05 01:41 | 8.0K | |
| Daurismo (Generic Gl..> | 2023-04-05 02:08 | 1.5K | |
| Daurismo (Generic Gl..> | 2023-04-05 02:03 | 880 | |
| Daurismo (Generic Gl..> | 2023-04-05 02:08 | 1.7K | |
| Daurismo (Generic Gl..> | 2023-04-05 02:03 | 1.0K | |
| Daurismo (Generic Gl..> | 2023-04-05 02:08 | 5.0K | |
| Daurismo (Generic Gl..> | 2023-04-05 02:03 | 3.0K | |
| Daurismo (Generic Gl..> | 2023-04-05 02:08 | 8.1K | |
| Daurismo (Generic Gl..> | 2023-04-05 02:03 | 5.1K | |
| Daurismo (Generic Gl..> | 2023-04-05 02:08 | 11K | |
| Daurismo (Generic Gl..> | 2023-04-05 02:03 | 7.1K | |
| Daxibotulinumtoxina-..> | 2023-04-05 03:15 | 2.3K | |
| Daxibotulinumtoxina-..> | 2023-04-05 03:09 | 1.3K | |
| Daxibotulinumtoxina-..> | 2023-04-05 03:15 | 4.1K | |
| Daxibotulinumtoxina-..> | 2023-04-05 03:09 | 2.3K | |
| Daxibotulinumtoxina-..> | 2023-04-05 03:15 | 11K | |
| Daxibotulinumtoxina-..> | 2023-04-05 03:09 | 7.3K | |
| Dayvigo (Generic Lem..> | 2023-04-05 03:15 | 1.3K | |
| Dayvigo (Generic Lem..> | 2023-04-05 03:14 | 534 | |
| Dayvigo (Generic Lem..> | 2023-04-05 03:15 | 1.6K | |
| Dayvigo (Generic Lem..> | 2023-04-05 03:14 | 652 | |
| Dayvigo (Generic Lem..> | 2023-04-05 03:15 | 4.5K | |
| Dayvigo (Generic Lem..> | 2023-04-05 03:14 | 1.8K | |
| Decitabine and cedaz..> | 2023-04-05 03:40 | 2.2K | |
| Decitabine and cedaz..> | 2023-04-05 03:40 | 1.3K | |
| Decitabine and cedaz..> | 2023-04-05 03:40 | 2.4K | |
| Decitabine and cedaz..> | 2023-04-05 03:40 | 1.4K | |
| Decitabine and cedaz..> | 2023-04-05 03:40 | 6.9K | |
| Decitabine and cedaz..> | 2023-04-05 03:40 | 4.0K | |
| Decitabine and cedaz..> | 2023-04-05 03:40 | 9.9K | |
| Decitabine and cedaz..> | 2023-04-05 03:40 | 5.5K | |
| Decitabine and cedaz..> | 2023-04-05 03:45 | 2.0K | |
| Decitabine and cedaz..> | 2023-04-05 03:40 | 1.3K | |
| Decitabine and cedaz..> | 2023-04-05 03:45 | 2.0K | |
| Decitabine and cedaz..> | 2023-04-05 03:40 | 1.2K | |
| Decitabine and cedaz..> | 2023-04-05 03:45 | 5.5K | |
| Decitabine and cedaz..> | 2023-04-05 03:40 | 3.4K | |
| Decitabine and cedaz..> | 2023-04-05 03:45 | 8.8K | |
| Decitabine and cedaz..> | 2023-04-05 03:40 | 5.2K | |
| Decitabine and cedaz..> | 2023-04-05 03:45 | 14K | |
| Decitabine and cedaz..> | 2023-04-05 03:40 | 8.5K | |
| Decitabine and cedaz..> | 2023-04-05 03:40 | 18K | |
| Decitabine and cedaz..> | 2023-04-05 03:40 | 9.9K | |
| Delstrigo (Generic D..> | 2023-04-05 04:37 | 1.7K | |
| Delstrigo (Generic D..> | 2023-04-05 04:31 | 804 | |
| Delstrigo (Generic D..> | 2023-04-05 04:37 | 1.9K | |
| Delstrigo (Generic D..> | 2023-04-05 04:31 | 918 | |
| Delstrigo (Generic D..> | 2023-04-05 04:37 | 4.9K | |
| Delstrigo (Generic D..> | 2023-04-05 04:31 | 2.3K | |
| Denavir (Generic Pen..> | 2023-04-05 04:51 | 3.3K | |
| Denavir (Generic Pen..> | 2023-04-05 04:51 | 2.1K | |
| Denavir (Generic Pen..> | 2023-04-05 04:51 | 4.6K | |
| Denavir (Generic Pen..> | 2023-04-05 04:51 | 2.9K | |
| Denavir (Generic Pen..> | 2023-04-05 04:51 | 13K | |
| Denavir (Generic Pen..> | 2023-04-05 04:51 | 7.8K | |
| Denavir (Generic Pen..> | 2023-04-05 04:51 | 15K | |
| Denavir (Generic Pen..> | 2023-04-05 04:51 | 9.2K | |
| Denavir (Generic Pen..> | 2023-04-05 04:56 | 3.0K | |
| Denavir (Generic Pen..> | 2023-04-05 04:51 | 2.2K | |
| Denavir (Generic Pen..> | 2023-04-05 04:56 | 4.1K | |
| Denavir (Generic Pen..> | 2023-04-05 04:51 | 2.9K | |
| Denavir (Generic Pen..> | 2023-04-05 04:56 | 11K | |
| Denavir (Generic Pen..> | 2023-04-05 04:51 | 7.6K | |
| Denavir (Generic Pen..> | 2023-04-05 04:56 | 14K | |
| Denavir (Generic Pen..> | 2023-04-05 04:51 | 9.5K | |
| Denavir (Generic Pen..> | 2023-04-05 04:56 | 24K | |
| Denavir (Generic Pen..> | 2023-04-05 04:51 | 16K | |
| Denavir (Generic Pen..> | 2023-04-05 04:51 | 24K | |
| Denavir (Generic Pen..> | 2023-04-05 04:51 | 17K | |
| Deucravacitinib-100x..> | 2023-04-05 04:57 | 1.6K | |
| Deucravacitinib-100x..> | 2023-04-05 04:57 | 654 | |
| Deucravacitinib-150x..> | 2023-04-05 04:57 | 1.5K | |
| Deucravacitinib-150x..> | 2023-04-05 04:57 | 546 | |
| Deucravacitinib-300x..> | 2023-04-05 04:57 | 3.6K | |
| Deucravacitinib-300x..> | 2023-04-05 04:57 | 1.3K | |
| Deucravacitinib-300x..> | 2023-04-05 04:57 | 7.2K | |
| Deucravacitinib-300x..> | 2023-04-05 04:57 | 3.3K | |
| Deucravacitinib-e168..> | 2023-04-05 05:06 | 1.4K | |
| Deucravacitinib-e168..> | 2023-04-05 04:57 | 646 | |
| Deucravacitinib-e168..> | 2023-04-05 05:06 | 1.9K | |
| Deucravacitinib-e168..> | 2023-04-05 04:57 | 778 | |
| Deucravacitinib-e168..> | 2023-04-05 05:06 | 4.4K | |
| Deucravacitinib-e168..> | 2023-04-05 04:57 | 1.8K | |
| Deucravacitinib-e168..> | 2023-04-05 05:06 | 6.6K | |
| Deucravacitinib-e168..> | 2023-04-05 04:57 | 3.3K | |
| Deucravacitinib-e168..> | 2023-04-05 05:06 | 8.6K | |
| Deucravacitinib-e168..> | 2023-04-05 04:57 | 3.5K | |
| Deucravacitinib.jpg | 2023-04-05 04:57 | 9.6K | |
| Deucravacitinib.jpg...> | 2023-04-05 04:57 | 3.5K | |
| Dexmedetomidine Subl..> | 2023-04-05 05:24 | 2.5K | |
| Dexmedetomidine Subl..> | 2023-04-05 05:19 | 1.7K | |
| Dexmedetomidine Subl..> | 2023-04-05 05:24 | 3.4K | |
| Dexmedetomidine Subl..> | 2023-04-05 05:19 | 2.1K | |
| Dexmedetomidine Subl..> | 2023-04-05 05:24 | 7.5K | |
| Dexmedetomidine Subl..> | 2023-04-05 05:19 | 5.5K | |
| Diacomit (Generic St..> | 2023-04-05 05:40 | 2.4K | |
| Diacomit (Generic St..> | 2023-04-05 05:35 | 1.6K | |
| Diacomit (Generic St..> | 2023-04-05 05:40 | 2.9K | |
| Diacomit (Generic St..> | 2023-04-05 05:35 | 1.8K | |
| Diacomit (Generic St..> | 2023-04-05 05:40 | 8.1K | |
| Diacomit (Generic St..> | 2023-04-05 05:35 | 5.0K | |
| Diacomit (Generic St..> | 2023-04-05 05:40 | 12K | |
| Diacomit (Generic St..> | 2023-04-05 05:35 | 7.2K | |
| Diacomit (Generic St..> | 2023-04-05 05:40 | 13K | |
| Diacomit (Generic St..> | 2023-04-05 05:35 | 9.8K | |
| Difelikefalin Inject..> | 2023-04-06 00:53 | 2.9K | |
| Difelikefalin Inject..> | 2023-04-06 00:48 | 1.9K | |
| Difelikefalin Inject..> | 2023-04-06 00:53 | 3.8K | |
| Difelikefalin Inject..> | 2023-04-06 00:48 | 2.7K | |
| Difelikefalin Inject..> | 2023-04-06 00:53 | 11K | |
| Difelikefalin Inject..> | 2023-04-06 00:48 | 8.3K | |
| Difelikefalin Inject..> | 2023-04-06 00:53 | 14K | |
| Difelikefalin Inject..> | 2023-04-06 00:48 | 8.9K | |
| Difelikefalin Inject..> | 2023-04-06 00:53 | 30K | |
| Difelikefalin Inject..> | 2023-04-06 00:48 | 22K | |
| Dilantin (Generic Ph..> | 2023-04-06 01:03 | 1.4K | |
| Dilantin (Generic Ph..> | 2023-04-06 00:59 | 674 | |
| Dilantin (Generic Ph..> | 2023-04-06 01:03 | 2.2K | |
| Dilantin (Generic Ph..> | 2023-04-06 00:59 | 1.2K | |
| Dilantin (Generic Ph..> | 2024-05-28 22:36 | 9.6K | |
| Dilantin (Generic Ph..> | 2024-05-28 22:36 | 33K | |
| Dilantin (Generic Ph..> | 2023-04-06 01:03 | 3.8K | |
| Dilantin (Generic Ph..> | 2023-04-06 00:59 | 2.5K | |
| Dilantin (Generic Ph..> | 2024-05-28 22:36 | 106K | |
| Diroximel Fumarate-1..> | 2023-04-06 00:14 | 2.5K | |
| Diroximel Fumarate-1..> | 2023-04-06 00:09 | 1.5K | |
| Diroximel Fumarate-1..> | 2023-04-06 00:14 | 4.0K | |
| Diroximel Fumarate-1..> | 2023-04-06 00:09 | 2.5K | |
| Diroximel Fumarate-3..> | 2023-04-06 00:14 | 11K | |
| Diroximel Fumarate-3..> | 2023-04-06 00:09 | 6.7K | |
| Diroximel Fumarate-3..> | 2023-04-06 00:14 | 12K | |
| Diroximel Fumarate-3..> | 2023-04-06 00:09 | 6.9K | |
| Diroximel Fumarate.jpg | 2023-04-06 00:14 | 21K | |
| Diroximel Fumarate.j..> | 2023-04-06 00:09 | 14K | |
| Doravirine-100x100.jpg | 2023-04-06 00:35 | 2.3K | |
| Doravirine-100x100.j..> | 2023-04-06 00:29 | 1.5K | |
| Doravirine-114x150.jpg | 2023-04-06 00:35 | 3.1K | |
| Doravirine-114x150.j..> | 2023-04-06 00:29 | 2.0K | |
| Doravirine-229x300.jpg | 2023-04-06 00:35 | 9.2K | |
| Doravirine-229x300.j..> | 2023-04-06 00:29 | 5.9K | |
| Doravirine-300x300.jpg | 2023-04-06 00:35 | 12K | |
| Doravirine-300x300.j..> | 2023-04-06 00:29 | 7.9K | |
| Doravirine.jpg | 2023-04-06 00:34 | 23K | |
| Doravirine.jpg.webp | 2023-04-06 00:29 | 17K | |
| Dostarlimab-gxly Inj..> | 2023-04-06 02:33 | 2.6K | |
| Dostarlimab-gxly Inj..> | 2023-04-06 02:33 | 1.5K | |
| Dostarlimab-gxly Inj..> | 2023-04-06 02:38 | 4.3K | |
| Dostarlimab-gxly Inj..> | 2023-04-06 02:33 | 2.7K | |
| Dostarlimab-gxly Inj..> | 2023-04-06 02:38 | 11K | |
| Dostarlimab-gxly Inj..> | 2023-04-06 02:33 | 6.9K | |
| Dostarlimab-gxly Inj..> | 2023-04-06 02:38 | 12K | |
| Dostarlimab-gxly Inj..> | 2023-04-06 02:33 | 6.9K | |
| Dostarlimab-gxly Inj..> | 2023-04-06 02:38 | 18K | |
| Dostarlimab-gxly Inj..> | 2023-04-06 02:33 | 12K | |
| Dovato (Generic Dolu..> | 2023-04-05 23:45 | 1.8K | |
| Dovato (Generic Dolu..> | 2023-04-05 23:40 | 1.2K | |
| Dovato (Generic Dolu..> | 2023-04-05 23:45 | 3.0K | |
| Dovato (Generic Dolu..> | 2023-04-05 23:40 | 1.9K | |
| Dovato (Generic Dolu..> | 2023-04-05 23:45 | 8.9K | |
| Dovato (Generic Dolu..> | 2023-04-05 23:40 | 5.8K | |
| Dovato (Generic Dolu..> | 2023-04-05 23:45 | 11K | |
| Dovato (Generic Dolu..> | 2023-04-05 23:40 | 6.9K | |
| Dovato (Generic Dolu..> | 2023-04-05 23:45 | 12K | |
| Dovato (Generic Dolu..> | 2023-04-05 23:40 | 9.5K | |
| Duobrii (Generic Hal..> | 2023-04-05 23:24 | 1.0K | |
| Duobrii (Generic Hal..> | 2023-04-05 23:24 | 390 | |
| Duobrii (Generic Hal..> | 2023-04-05 23:24 | 1.6K | |
| Duobrii (Generic Hal..> | 2023-04-05 23:24 | 726 | |
| Duobrii (Generic Hal..> | 2023-04-05 23:24 | 4.1K | |
| Duobrii (Generic Hal..> | 2023-04-05 23:24 | 2.0K | |
| Duobrii (Generic Hal..> | 2023-04-05 23:29 | 1.4K | |
| Duobrii (Generic Hal..> | 2023-04-05 23:24 | 828 | |
| Duobrii (Generic Hal..> | 2023-04-05 23:29 | 1.6K | |
| Duobrii (Generic Hal..> | 2023-04-05 23:24 | 820 | |
| Duobrii (Generic Hal..> | 2023-04-05 23:29 | 3.9K | |
| Duobrii (Generic Hal..> | 2023-04-05 23:24 | 2.2K | |
| Duobrii (Generic Hal..> | 2023-04-05 23:29 | 6.2K | |
| Duobrii (Generic Hal..> | 2023-04-05 23:24 | 3.9K | |
| Duobrii (Generic Hal..> | 2023-04-05 23:29 | 7.7K | |
| Duobrii (Generic Hal..> | 2023-04-05 23:24 | 4.5K | |
| Duobrii (Generic Hal..> | 2023-04-05 23:24 | 7.2K | |
| Duobrii (Generic Hal..> | 2023-04-05 23:24 | 4.5K | |
| Duobrii (Generic Taz..> | 2023-04-05 22:58 | 2.1K | |
| Duobrii (Generic Taz..> | 2023-04-05 22:51 | 1.3K | |
| Duobrii (Generic Taz..> | 2023-04-05 22:58 | 2.9K | |
| Duobrii (Generic Taz..> | 2023-04-05 22:51 | 1.8K | |
| Duobrii (Generic Taz..> | 2023-04-05 22:51 | 7.4K | |
| Duobrii (Generic Taz..> | 2023-04-05 22:51 | 5.4K | |
| Dymista Nasal Spray ..> | 2023-04-05 22:48 | 13K | |
| Dymista Nasal Spray ..> | 2023-04-05 22:43 | 8.7K | |
| Dymista Nasal Spray ..> | 2023-04-05 22:48 | 20K | |
| Dymista Nasal Spray ..> | 2023-04-05 22:43 | 14K | |
| Dymista Nasal Spray ..> | 2023-04-05 22:48 | 23K | |
| Dymista Nasal Spray ..> | 2023-04-05 22:43 | 21K | |
| Dymista Nasal Spray ..> | 2023-04-05 22:26 | 2.5K | |
| Dymista Nasal Spray ..> | 2023-04-05 22:21 | 1.6K | |
| Dymista Nasal Spray ..> | 2023-04-05 22:26 | 3.6K | |
| Dymista Nasal Spray ..> | 2023-04-05 22:21 | 2.3K | |
| Dymista Nasal Spray ..> | 2023-04-05 22:21 | 11K | |
| Dymista Nasal Spray ..> | 2023-04-05 22:21 | 5.8K | |
| Dymista Nasal Spray ..> | 2023-04-05 22:26 | 12K | |
| Dymista Nasal Spray ..> | 2023-04-05 22:21 | 6.9K | |
| Dymista Nasal Spray ..> | 2023-04-05 22:26 | 14K | |
| Dymista Nasal Spray ..> | 2023-04-05 22:21 | 9.5K | |
| Edaravone Oral-100x1..> | 2023-04-21 22:37 | 1.8K | |
| Edaravone Oral-100x1..> | 2023-04-21 22:32 | 1.0K | |
| Edaravone Oral-139x1..> | 2023-04-21 22:37 | 2.9K | |
| Edaravone Oral-139x1..> | 2023-04-21 22:32 | 1.6K | |
| Edaravone Oral-279x3..> | 2023-04-21 22:37 | 7.7K | |
| Edaravone Oral-279x3..> | 2023-04-21 22:32 | 3.6K | |
| Edaravone Oral-300x3..> | 2023-04-21 22:37 | 7.8K | |
| Edaravone Oral-300x3..> | 2023-04-21 22:32 | 3.8K | |
| Edaravone Oral-e1682..> | 2023-04-21 22:45 | 1.9K | |
| Edaravone Oral-e1682..> | 2023-04-21 22:45 | 1.0K | |
| Edaravone Oral-e1682..> | 2023-04-21 22:45 | 3.1K | |
| Edaravone Oral-e1682..> | 2023-04-21 22:45 | 1.6K | |
| Edaravone Oral-e1682..> | 2023-04-21 22:45 | 8.1K | |
| Edaravone Oral-e1682..> | 2023-04-21 22:45 | 3.6K | |
| Edaravone Oral-e1682..> | 2023-04-21 22:45 | 8.4K | |
| Edaravone Oral-e1682..> | 2023-04-21 22:45 | 3.8K | |
| Edaravone Oral-e1682..> | 2023-04-21 22:45 | 10K | |
| Edaravone Oral-e1682..> | 2023-04-21 22:45 | 4.9K | |
| Edaravone Oral.jpg | 2023-04-21 22:37 | 8.3K | |
| Edaravone Oral.jpg.webp | 2023-04-21 22:32 | 4.8K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:00 | 2.6K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:00 | 1.6K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:00 | 2.9K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:00 | 1.7K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:00 | 9.1K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:00 | 5.3K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:00 | 14K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:00 | 8.1K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:01 | 2.4K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:01 | 1.3K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:01 | 3.3K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:01 | 1.8K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:01 | 8.6K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:01 | 4.2K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:01 | 11K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:01 | 5.1K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:01 | 13K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:01 | 6.3K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:05 | 2.4K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:03 | 1.5K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:05 | 3.2K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:03 | 1.9K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:05 | 8.4K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:03 | 4.4K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:05 | 11K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:03 | 6.3K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:05 | 12K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:03 | 6.3K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:00 | 25K | |
| Efgartigimod alfa-fc..> | 2023-04-21 23:00 | 13K | |
| Egaten (Generic Tric..> | 2023-04-21 23:30 | 1.7K | |
| Egaten (Generic Tric..> | 2023-04-21 23:25 | 894 | |
| Egaten (Generic Tric..> | 2023-04-21 23:30 | 2.9K | |
| Egaten (Generic Tric..> | 2023-04-21 23:25 | 1.6K | |
| Egaten (Generic Tric..> | 2023-04-21 23:30 | 5.2K | |
| Egaten (Generic Tric..> | 2023-04-21 23:25 | 3.3K | |
| Elacestrant-100x100.jpg | 2023-04-21 23:46 | 2.1K | |
| Elacestrant-100x100...> | 2023-04-21 23:41 | 1.3K | |
| Elacestrant-116x150.jpg | 2023-04-21 23:46 | 2.9K | |
| Elacestrant-116x150...> | 2023-04-21 23:41 | 1.8K | |
| Elacestrant-233x300.jpg | 2023-04-21 23:46 | 7.7K | |
| Elacestrant-233x300...> | 2023-04-21 23:41 | 4.4K | |
| Elacestrant-300x300.jpg | 2023-04-21 23:46 | 9.3K | |
| Elacestrant-300x300...> | 2023-04-21 23:41 | 5.2K | |
| Elacestrant.jpg | 2023-04-21 23:46 | 19K | |
| Elacestrant.jpg.webp | 2023-04-21 23:41 | 10K | |
| Elagolix, Estradiol,..> | 2023-04-22 00:12 | 1.7K | |
| Elagolix, Estradiol,..> | 2023-04-22 00:07 | 748 | |
| Elagolix, Estradiol,..> | 2023-04-22 00:12 | 2.5K | |
| Elagolix, Estradiol,..> | 2023-04-22 00:07 | 1.0K | |
| Elagolix, Estradiol,..> | 2023-04-22 00:12 | 4.4K | |
| Elagolix, Estradiol,..> | 2023-04-22 00:07 | 1.7K | |
| Elagolix-100x100.jpg | 2023-04-22 00:01 | 2.4K | |
| Elagolix-100x100.jpg..> | 2023-04-22 00:01 | 1.2K | |
| Elagolix-150x113.jpg | 2023-04-22 00:01 | 3.0K | |
| Elagolix-150x113.jpg..> | 2023-04-22 00:01 | 1.5K | |
| Elagolix-300x225.jpg | 2023-04-22 00:01 | 8.2K | |
| Elagolix-300x225.jpg..> | 2023-04-22 00:01 | 3.8K | |
| Elagolix-300x300.jpg | 2023-04-22 00:01 | 11K | |
| Elagolix-300x300.jpg..> | 2023-04-22 00:01 | 5.1K | |
| Elagolix-e1682146919..> | 2023-04-22 00:12 | 2.2K | |
| Elagolix-e1682146919..> | 2023-04-22 00:02 | 1.2K | |
| Elagolix-e1682146919..> | 2023-04-22 00:12 | 3.6K | |
| Elagolix-e1682146919..> | 2023-04-22 00:02 | 2.1K | |
| Elagolix-e1682146919..> | 2023-04-22 00:12 | 9.9K | |
| Elagolix-e1682146919..> | 2023-04-22 00:02 | 4.9K | |
| Elagolix-e1682146919..> | 2023-04-22 00:12 | 10K | |
| Elagolix-e1682146919..> | 2023-04-22 00:02 | 4.9K | |
| Elagolix-e1682146919..> | 2023-04-22 00:12 | 19K | |
| Elagolix-e1682146919..> | 2023-04-22 00:02 | 10K | |
| Elagolix.jpg | 2023-04-22 00:01 | 24K | |
| Elagolix.jpg.webp | 2023-04-22 00:01 | 10K | |
| Elahere (Generic Mir..> | 2023-04-22 00:42 | 2.7K | |
| Elahere (Generic Mir..> | 2023-04-22 00:42 | 1.7K | |
| Elahere (Generic Mir..> | 2023-04-22 00:42 | 3.7K | |
| Elahere (Generic Mir..> | 2023-04-22 00:42 | 2.2K | |
| Elahere (Generic Mir..> | 2023-04-22 00:42 | 11K | |
| Elahere (Generic Mir..> | 2023-04-22 00:42 | 6.2K | |
| Elahere (Generic Mir..> | 2023-04-22 00:42 | 14K | |
| Elahere (Generic Mir..> | 2023-04-22 00:42 | 8.0K | |
| Elahere (Generic Mir..> | 2023-04-22 00:47 | 2.5K | |
| Elahere (Generic Mir..> | 2023-04-22 00:42 | 1.7K | |
| Elahere (Generic Mir..> | 2023-04-22 00:47 | 3.9K | |
| Elahere (Generic Mir..> | 2023-04-22 00:42 | 2.6K | |
| Elahere (Generic Mir..> | 2023-04-22 00:47 | 11K | |
| Elahere (Generic Mir..> | 2023-04-22 00:42 | 7.1K | |
| Elahere (Generic Mir..> | 2023-04-22 00:47 | 12K | |
| Elahere (Generic Mir..> | 2023-04-22 00:42 | 7.9K | |
| Elahere (Generic Mir..> | 2023-04-22 00:47 | 27K | |
| Elahere (Generic Mir..> | 2023-04-22 00:42 | 18K | |
| Elahere (Generic Mir..> | 2023-04-22 00:42 | 26K | |
| Elahere (Generic Mir..> | 2023-04-22 00:42 | 18K | |
| Elepsia XR (Generic ..> | 2023-04-22 03:08 | 1.9K | |
| Elepsia XR (Generic ..> | 2023-04-22 00:58 | 932 | |
| Elepsia XR (Generic ..> | 2023-04-22 03:08 | 2.4K | |
| Elepsia XR (Generic ..> | 2023-04-22 00:58 | 1.1K | |
| Elepsia XR (Generic ..> | 2023-04-22 03:08 | 5.7K | |
| Elepsia XR (Generic ..> | 2023-04-22 00:58 | 2.7K | |
| Elestat (Generic Epi..> | 2023-04-17 00:54 | 2.7K | |
| Elestat (Generic Epi..> | 2023-04-17 00:49 | 1.8K | |
| Elestat (Generic Epi..> | 2023-04-17 00:54 | 3.7K | |
| Elestat (Generic Epi..> | 2023-04-17 00:49 | 2.4K | |
| Elestat (Generic Epi..> | 2023-04-17 00:54 | 9.2K | |
| Elestat (Generic Epi..> | 2023-04-17 00:49 | 5.6K | |
| Elzonris (Generic Ta..> | 2023-04-22 03:08 | 1.9K | |
| Elzonris (Generic Ta..> | 2023-04-22 03:03 | 1.1K | |
| Elzonris (Generic Ta..> | 2023-04-22 03:08 | 3.3K | |
| Elzonris (Generic Ta..> | 2023-04-22 03:03 | 2.1K | |
| Elzonris (Generic Ta..> | 2023-04-22 03:08 | 9.1K | |
| Elzonris (Generic Ta..> | 2023-04-22 03:03 | 5.5K | |
| Elzonris (Generic Ta..> | 2023-04-22 03:08 | 18K | |
| Elzonris (Generic Ta..> | 2023-04-22 03:03 | 11K | |
| Emapalumab-lzsg Inje..> | 2023-04-22 03:28 | 3.5K | |
| Emapalumab-lzsg Inje..> | 2023-04-22 03:23 | 2.6K | |
| Emapalumab-lzsg Inje..> | 2023-04-22 03:28 | 4.9K | |
| Emapalumab-lzsg Inje..> | 2023-04-22 03:23 | 3.6K | |
| Emapalumab-lzsg Inje..> | 2023-04-22 03:28 | 10K | |
| Emapalumab-lzsg Inje..> | 2023-04-22 03:23 | 8.7K | |
| Emgality (Generic Ga..> | 2023-04-22 03:59 | 1.4K | |
| Emgality (Generic Ga..> | 2023-04-22 03:54 | 702 | |
| Emgality (Generic Ga..> | 2023-04-22 03:59 | 2.1K | |
| Emgality (Generic Ga..> | 2023-04-22 03:54 | 1.2K | |
| Emgality (Generic Ga..> | 2023-04-22 03:59 | 6.0K | |
| Emgality (Generic Ga..> | 2023-04-22 03:54 | 3.4K | |
| Emgality (Generic Ga..> | 2023-04-22 03:54 | 7.6K | |
| Emgality (Generic Ga..> | 2023-04-22 03:54 | 3.5K | |
| Emgality (Generic Ga..> | 2023-04-22 03:59 | 15K | |
| Emgality (Generic Ga..> | 2023-04-22 03:54 | 9.8K | |
| Emicizumab-kxwh Inje..> | 2023-04-22 04:09 | 2.3K | |
| Emicizumab-kxwh Inje..> | 2023-04-22 04:01 | 1.4K | |
| Emicizumab-kxwh Inje..> | 2023-04-22 04:09 | 3.4K | |
| Emicizumab-kxwh Inje..> | 2023-04-22 04:01 | 2.2K | |
| Emicizumab-kxwh Inje..> | 2023-04-22 04:09 | 9.9K | |
| Emicizumab-kxwh Inje..> | 2023-04-22 04:01 | 6.5K | |
| Emicizumab-kxwh Inje..> | 2023-04-22 04:09 | 11K | |
| Emicizumab-kxwh Inje..> | 2023-04-22 04:01 | 7.2K | |
| Emicizumab-kxwh Inje..> | 2023-04-22 04:09 | 24K | |
| Emicizumab-kxwh Inje..> | 2023-04-22 04:01 | 18K | |
| Empaveli (Generic Pe..> | 2023-04-22 04:39 | 11K | |
| Empaveli (Generic Pe..> | 2023-04-22 04:34 | 7.5K | |
| Empaveli (Generic Pe..> | 2023-04-22 04:39 | 23K | |
| Empaveli (Generic Pe..> | 2023-04-22 04:34 | 15K | |
| Empaveli (Generic Pe..> | 2023-04-22 04:39 | 62K | |
| Empaveli (Generic Pe..> | 2023-04-22 04:34 | 39K | |
| Encorafenib-100x100.jpg | 2023-04-22 05:03 | 1.9K | |
| Encorafenib-100x100...> | 2023-04-22 04:58 | 1.1K | |
| Encorafenib-150x150.jpg | 2023-04-22 05:03 | 3.2K | |
| Encorafenib-150x150...> | 2023-04-22 04:58 | 1.9K | |
| Encorafenib-300x300.jpg | 2023-04-22 05:03 | 8.6K | |
| Encorafenib-300x300...> | 2023-04-22 04:58 | 4.7K | |
| Encorafenib.jpg | 2023-04-22 05:03 | 16K | |
| Encorafenib.jpg.webp | 2023-04-22 04:58 | 9.5K | |
| Endari (Generic L-gl..> | 2023-04-22 05:34 | 1.9K | |
| Endari (Generic L-gl..> | 2023-04-22 05:29 | 1.1K | |
| Endari (Generic L-gl..> | 2023-04-22 05:34 | 2.2K | |
| Endari (Generic L-gl..> | 2023-04-22 05:29 | 1.1K | |
| Endari (Generic L-gl..> | 2023-04-22 05:34 | 5.4K | |
| Endari (Generic L-gl..> | 2023-04-22 05:29 | 2.6K | |
| Endari (Generic L-gl..> | 2023-04-22 05:34 | 8.6K | |
| Endari (Generic L-gl..> | 2023-04-22 05:29 | 4.3K | |
| Endari (Generic L-gl..> | 2023-04-22 05:34 | 11K | |
| Endari (Generic L-gl..> | 2023-04-22 05:29 | 6.7K | |
| Endometrin (Generic ..> | 2023-04-22 05:57 | 2.9K | |
| Endometrin (Generic ..> | 2023-04-22 05:52 | 2.0K | |
| Endometrin (Generic ..> | 2023-04-22 05:57 | 5.0K | |
| Endometrin (Generic ..> | 2023-04-22 05:52 | 3.6K | |
| Endometrin (Generic ..> | 2023-04-22 05:56 | 8.4K | |
| Endometrin (Generic ..> | 2023-04-22 05:52 | 6.6K | |
| Enfortumab vedotin-e..> | 2023-04-23 23:46 | 1.6K | |
| Enfortumab vedotin-e..> | 2023-04-23 23:41 | 910 | |
| Enfortumab vedotin-e..> | 2023-04-23 23:46 | 2.2K | |
| Enfortumab vedotin-e..> | 2023-04-23 23:41 | 1.3K | |
| Enfortumab vedotin-e..> | 2023-04-23 23:46 | 5.8K | |
| Enfortumab vedotin-e..> | 2023-04-23 23:41 | 3.4K | |
| Enfortumab vedotin-e..> | 2023-04-23 23:46 | 7.3K | |
| Enfortumab vedotin-e..> | 2023-04-23 23:41 | 4.3K | |
| Enfortumab vedotin-e..> | 2023-04-23 23:46 | 8.8K | |
| Enfortumab vedotin-e..> | 2023-04-23 23:41 | 5.7K | |
| Enhertu (Generic Fam..> | 2023-04-24 00:05 | 2.8K | |
| Enhertu (Generic Fam..> | 2023-04-24 00:00 | 1.9K | |
| Enhertu (Generic Fam..> | 2023-04-24 00:05 | 3.8K | |
| Enhertu (Generic Fam..> | 2023-04-24 00:00 | 2.6K | |
| Enhertu (Generic Fam..> | 2023-04-24 00:05 | 12K | |
| Enhertu (Generic Fam..> | 2023-04-24 00:00 | 8.2K | |
| Enhertu (Generic Fam..> | 2023-04-24 00:05 | 15K | |
| Enhertu (Generic Fam..> | 2023-04-24 00:00 | 10K | |
| Enhertu (Generic Fam..> | 2023-04-24 00:05 | 28K | |
| Enhertu (Generic Fam..> | 2023-04-24 00:00 | 23K | |
| Enjaymo (Generic Sut..> | 2023-04-24 00:38 | 2.4K | |
| Enjaymo (Generic Sut..> | 2023-04-24 00:33 | 1.6K | |
| Enjaymo (Generic Sut..> | 2023-04-24 00:38 | 3.9K | |
| Enjaymo (Generic Sut..> | 2023-04-24 00:33 | 2.7K | |
| Enjaymo (Generic Sut..> | 2023-04-24 00:38 | 12K | |
| Enjaymo (Generic Sut..> | 2023-04-24 00:33 | 7.9K | |
| Enjaymo (Generic Sut..> | 2023-04-24 00:38 | 13K | |
| Enjaymo (Generic Sut..> | 2023-04-24 00:33 | 8.7K | |
| Enjaymo (Generic Sut..> | 2023-04-24 00:38 | 27K | |
| Enjaymo (Generic Sut..> | 2023-04-24 00:33 | 22K | |
| Enspryng (Generic Sa..> | 2023-04-23 23:24 | 2.3K | |
| Enspryng (Generic Sa..> | 2023-04-23 23:19 | 1.4K | |
| Enspryng (Generic Sa..> | 2023-04-23 23:24 | 3.5K | |
| Enspryng (Generic Sa..> | 2023-04-23 23:19 | 2.1K | |
| Enspryng (Generic Sa..> | 2023-04-23 23:24 | 9.7K | |
| Enspryng (Generic Sa..> | 2023-04-23 23:19 | 6.2K | |
| Enspryng (Generic Sa..> | 2023-04-23 23:24 | 12K | |
| Enspryng (Generic Sa..> | 2023-04-23 23:19 | 7.4K | |
| Enspryng (Generic Sa..> | 2023-04-23 23:24 | 28K | |
| Enspryng (Generic Sa..> | 2023-04-23 23:19 | 17K | |
| Entrectinib-100x100...> | 2023-04-11 06:02 | 1.8K | |
| Entrectinib-100x100...> | 2023-04-11 05:57 | 1.2K | |
| Entrectinib-141x150...> | 2023-04-11 06:02 | 2.9K | |
| Entrectinib-141x150...> | 2023-04-11 05:57 | 1.8K | |
| Entrectinib-281x300...> | 2023-04-11 06:02 | 8.2K | |
| Entrectinib-281x300...> | 2023-04-11 05:57 | 4.4K | |
| Entrectinib-300x300...> | 2023-04-11 06:02 | 9.0K | |
| Entrectinib-300x300...> | 2023-04-11 05:57 | 5.0K | |
| Entrectinib.jpeg | 2023-04-11 06:02 | 20K | |
| Entrectinib.jpeg.webp | 2023-04-11 05:57 | 11K | |
| Entresto (Generic Va..> | 2023-04-23 22:44 | 1.8K | |
| Entresto (Generic Va..> | 2023-04-23 22:39 | 1.0K | |
| Entresto (Generic Va..> | 2023-04-23 22:44 | 3.1K | |
| Entresto (Generic Va..> | 2023-04-23 22:39 | 1.8K | |
| Entresto (Generic Va..> | 2023-04-23 22:44 | 9.0K | |
| Entresto (Generic Va..> | 2023-04-23 22:39 | 4.8K | |
| Entresto (Generic Va..> | 2023-04-23 22:44 | 9.6K | |
| Entresto (Generic Va..> | 2023-04-23 22:39 | 5.1K | |
| Entresto (Generic Va..> | 2023-04-23 22:44 | 13K | |
| Entresto (Generic Va..> | 2023-04-23 22:39 | 8.7K | |
| Envarsus XR (Generic..> | 2023-04-21 05:50 | 1.5K | |
| Envarsus XR (Generic..> | 2023-04-21 05:45 | 650 | |
| Envarsus XR (Generic..> | 2023-04-21 05:50 | 1.8K | |
| Envarsus XR (Generic..> | 2023-04-21 05:45 | 712 | |
| Envarsus XR (Generic..> | 2023-04-21 05:50 | 2.7K | |
| Envarsus XR (Generic..> | 2023-04-21 05:45 | 1.3K | |
| Epiduo Forte (Generi..> | 2023-04-16 23:09 | 1.1K | |
| Epiduo Forte (Generi..> | 2023-04-16 23:04 | 566 | |
| Epiduo Forte (Generi..> | 2023-04-16 23:09 | 1.5K | |
| Epiduo Forte (Generi..> | 2023-04-16 23:04 | 708 | |
| Epiduo Forte (Generi..> | 2023-04-16 23:09 | 3.8K | |
| Epiduo Forte (Generi..> | 2023-04-16 23:04 | 2.0K | |
| Epiduo Forte (Generi..> | 2023-04-16 23:09 | 5.2K | |
| Epiduo Forte (Generi..> | 2023-04-16 23:04 | 2.7K | |
| Epiduo Forte (Generi..> | 2023-04-16 23:09 | 11K | |
| Epiduo Forte (Generi..> | 2023-04-16 23:04 | 5.8K | |
| Epinephrine Oral Inh..> | 2023-04-21 04:11 | 3.0K | |
| Epinephrine Oral Inh..> | 2023-04-21 04:06 | 2.1K | |
| Epinephrine Oral Inh..> | 2023-04-21 04:11 | 5.1K | |
| Epinephrine Oral Inh..> | 2023-04-21 04:06 | 3.7K | |
| Epinephrine Oral Inh..> | 2023-04-21 04:11 | 14K | |
| Epinephrine Oral Inh..> | 2023-04-21 04:06 | 9.5K | |
| Epinephrine Oral Inh..> | 2023-04-21 04:11 | 15K | |
| Epinephrine Oral Inh..> | 2023-04-21 04:06 | 10K | |
| Epinephrine Oral Inh..> | 2023-04-21 04:11 | 12K | |
| Epoprostenol-100x100..> | 2023-04-21 03:35 | 1.9K | |
| Epoprostenol-100x100..> | 2023-04-21 03:35 | 1.1K | |
| Epoprostenol-150x105..> | 2023-04-21 03:35 | 2.2K | |
| Epoprostenol-150x105..> | 2023-04-21 03:35 | 1.2K | |
| Epoprostenol-300x210..> | 2023-04-21 03:35 | 6.6K | |
| Epoprostenol-300x210..> | 2023-04-21 03:35 | 3.5K | |
| Epoprostenol-300x300..> | 2023-04-21 03:35 | 10K | |
| Epoprostenol-300x300..> | 2023-04-21 03:35 | 5.8K | |
| Epoprostenol-e168207..> | 2023-04-21 03:40 | 2.0K | |
| Epoprostenol-e168207..> | 2023-04-21 03:36 | 1.3K | |
| Epoprostenol-e168207..> | 2023-04-21 03:40 | 3.1K | |
| Epoprostenol-e168207..> | 2023-04-21 03:36 | 2.0K | |
| Epoprostenol-e168207..> | 2023-04-21 03:40 | 9.0K | |
| Epoprostenol-e168207..> | 2023-04-21 03:36 | 5.7K | |
| Epoprostenol-e168207..> | 2023-04-21 03:40 | 9.9K | |
| Epoprostenol-e168207..> | 2023-04-21 03:36 | 6.5K | |
| Epoprostenol-e168207..> | 2023-04-21 03:40 | 16K | |
| Epoprostenol-e168207..> | 2023-04-21 03:36 | 10K | |
| Epoprostenol.jpeg | 2023-04-21 03:35 | 29K | |
| Epoprostenol.jpeg.webp | 2023-04-21 03:35 | 11K | |
| Eprontia (Generic To..> | 2023-04-21 03:08 | 1.3K | |
| Eprontia (Generic To..> | 2023-04-21 03:07 | 502 | |
| Eprontia (Generic To..> | 2023-04-21 03:08 | 1.8K | |
| Eprontia (Generic To..> | 2023-04-21 03:07 | 658 | |
| Eprontia (Generic To..> | 2023-04-21 03:08 | 3.9K | |
| Eprontia (Generic To..> | 2023-04-21 03:07 | 1.9K | |
| Eptinezumab-jjmr Inj..> | 2023-04-21 03:08 | 2.7K | |
| Eptinezumab-jjmr Inj..> | 2023-04-21 03:02 | 1.9K | |
| Eptinezumab-jjmr Inj..> | 2023-04-21 03:08 | 3.7K | |
| Eptinezumab-jjmr Inj..> | 2023-04-21 03:02 | 2.6K | |
| Eptinezumab-jjmr Inj..> | 2023-04-21 03:08 | 9.6K | |
| Eptinezumab-jjmr Inj..> | 2023-04-21 03:02 | 6.3K | |
| Eptinezumab-jjmr Inj..> | 2023-04-21 03:08 | 12K | |
| Eptinezumab-jjmr Inj..> | 2023-04-21 03:02 | 7.6K | |
| Eptinezumab-jjmr Inj..> | 2023-04-21 03:08 | 18K | |
| Eptinezumab-jjmr Inj..> | 2023-04-21 03:02 | 12K | |
| Equanil (Generic Mep..> | 2023-04-15 03:15 | 1.4K | |
| Equanil (Generic Mep..> | 2023-04-15 03:10 | 606 | |
| Equanil (Generic Mep..> | 2023-04-15 03:15 | 1.7K | |
| Equanil (Generic Mep..> | 2023-04-15 03:10 | 720 | |
| Equanil (Generic Mep..> | 2023-04-15 03:15 | 4.5K | |
| Equanil (Generic Mep..> | 2023-04-15 03:10 | 1.8K | |
| Equanil (Generic Mep..> | 2023-04-15 03:15 | 5.9K | |
| Equanil (Generic Mep..> | 2023-04-15 03:10 | 2.3K | |
| Equanil (Generic Mep..> | 2023-04-15 03:15 | 11K | |
| Equanil (Generic Mep..> | 2023-04-15 03:10 | 4.4K | |
| Eravacycline Injecti..> | 2023-04-21 02:20 | 1.9K | |
| Eravacycline Injecti..> | 2023-04-21 02:15 | 1.1K | |
| Eravacycline Injecti..> | 2023-04-21 02:20 | 3.3K | |
| Eravacycline Injecti..> | 2023-04-21 02:15 | 2.2K | |
| Eravacycline Injecti..> | 2023-04-21 02:20 | 8.1K | |
| Eravacycline Injecti..> | 2023-04-21 02:15 | 5.5K | |
| Erelzi (Generic Etan..> | 2023-04-10 02:15 | 1.9K | |
| Erelzi (Generic Etan..> | 2023-04-10 02:10 | 1.1K | |
| Erelzi (Generic Etan..> | 2023-04-10 02:15 | 2.5K | |
| Erelzi (Generic Etan..> | 2023-04-10 02:10 | 1.6K | |
| Erelzi (Generic Etan..> | 2023-04-10 02:15 | 6.4K | |
| Erelzi (Generic Etan..> | 2023-04-10 02:10 | 4.0K | |
| Erelzi (Generic Etan..> | 2023-04-10 02:15 | 8.2K | |
| Erelzi (Generic Etan..> | 2023-04-10 02:10 | 5.2K | |
| Erelzi (Generic Etan..> | 2023-04-10 02:15 | 12K | |
| Erelzi (Generic Etan..> | 2023-04-10 02:10 | 7.6K | |
| Esketamine Nasal Spr..> | 2023-04-21 01:11 | 949 | |
| Esketamine Nasal Spr..> | 2023-04-21 01:01 | 384 | |
| Esketamine Nasal Spr..> | 2023-04-21 01:11 | 1.5K | |
| Esketamine Nasal Spr..> | 2023-04-21 01:01 | 710 | |
| Esketamine Nasal Spr..> | 2023-04-21 01:11 | 3.8K | |
| Esketamine Nasal Spr..> | 2023-04-21 01:01 | 1.9K | |
| Esketamine Nasal Spr..> | 2023-04-21 01:11 | 7.5K | |
| Esketamine Nasal Spr..> | 2023-04-21 01:01 | 4.5K | |
| Esomeprazole Injecti..> | 2023-04-13 04:27 | 1.4M | |
| Estrogen Replacement..> | 2023-04-12 02:53 | 1.5K | |
| Estrogen Replacement..> | 2023-04-12 02:48 | 950 | |
| Estrogen Replacement..> | 2023-04-12 02:48 | 2.8K | |
| Estrogen Replacement..> | 2023-04-12 02:48 | 1.6K | |
| Estrogen Replacement..> | 2023-04-12 02:53 | 7.7K | |
| Estrogen Replacement..> | 2023-04-12 02:48 | 5.0K | |
| Estrogen Replacement..> | 2023-04-12 02:53 | 19K | |
| Estrogen Replacement..> | 2023-04-12 02:48 | 12K | |
| Estrostep Fe (Generi..> | 2023-04-10 23:29 | 1.5K | |
| Estrostep Fe (Generi..> | 2023-04-10 23:24 | 852 | |
| Estrostep Fe (Generi..> | 2023-04-10 23:29 | 2.6K | |
| Estrostep Fe (Generi..> | 2023-04-10 23:24 | 1.6K | |
| Estrostep Fe (Generi..> | 2023-04-10 23:29 | 7.6K | |
| Estrostep Fe (Generi..> | 2023-04-10 23:24 | 4.7K | |
| Estrostep Fe (Generi..> | 2023-04-10 23:29 | 15K | |
| Estrostep Fe (Generi..> | 2023-04-10 23:24 | 9.6K | |
| Eszopiclone-100x100.jpg | 2023-04-21 01:01 | 1.5K | |
| Eszopiclone-100x100...> | 2023-04-21 00:56 | 714 | |
| Eszopiclone-150x113.jpg | 2023-04-21 01:01 | 2.3K | |
| Eszopiclone-150x113...> | 2023-04-21 00:56 | 1.0K | |
| Eszopiclone.jpg | 2023-04-21 01:01 | 4.8K | |
| Eszopiclone.jpg.webp | 2023-04-21 00:56 | 2.4K | |
| Ethambutol-100x100.jpg | 2023-04-21 00:43 | 1.3K | |
| Ethambutol-100x100.j..> | 2023-04-21 00:38 | 502 | |
| Ethambutol-150x113.jpg | 2023-04-21 00:43 | 1.8K | |
| Ethambutol-150x113.j..> | 2023-04-21 00:38 | 650 | |
| Ethambutol.jpg | 2023-04-21 00:43 | 3.3K | |
| Ethambutol.jpg.webp | 2023-04-21 00:38 | 1.6K | |
| Etranacogene dezapar..> | 2023-04-21 00:18 | 3.4K | |
| Etranacogene dezapar..> | 2023-04-21 00:13 | 2.4K | |
| Etranacogene dezapar..> | 2023-04-21 00:18 | 3.2K | |
| Etranacogene dezapar..> | 2023-04-21 00:13 | 2.3K | |
| Etranacogene dezapar..> | 2023-04-21 00:18 | 9.4K | |
| Etranacogene dezapar..> | 2023-04-21 00:13 | 6.9K | |
| Etranacogene dezapar..> | 2023-04-21 00:18 | 17K | |
| Etranacogene dezapar..> | 2023-04-21 00:13 | 12K | |
| Etranacogene dezapar..> | 2023-04-21 00:18 | 28K | |
| Etranacogene dezapar..> | 2023-04-21 00:13 | 19K | |
| Eulexin (Generic Flu..> | 2023-04-20 23:56 | 1.6K | |
| Eulexin (Generic Flu..> | 2023-04-20 23:50 | 806 | |
| Eulexin (Generic Flu..> | 2023-04-20 23:56 | 1.9K | |
| Eulexin (Generic Flu..> | 2023-04-20 23:50 | 848 | |
| Eulexin (Generic Flu..> | 2023-04-20 23:56 | 3.6K | |
| Eulexin (Generic Flu..> | 2023-04-20 23:50 | 1.8K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:15 | 2.7K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:15 | 1.6K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:15 | 3.0K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:15 | 1.7K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:15 | 8.2K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:15 | 4.2K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:15 | 12K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:15 | 6.1K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:20 | 2.3K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:16 | 1.6K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:20 | 4.0K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:16 | 2.5K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:20 | 11K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:16 | 5.8K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:20 | 11K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:16 | 6.1K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:20 | 18K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:16 | 9.8K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:15 | 33K | |
| Evekeo ODT (Generic ..> | 2023-04-11 05:15 | 9.9K | |
| Evenity (Generic Rom..> | 2023-04-20 23:15 | 1.9K | |
| Evenity (Generic Rom..> | 2023-04-20 23:15 | 1.1K | |
| Evenity (Generic Rom..> | 2023-04-20 23:15 | 3.0K | |
| Evenity (Generic Rom..> | 2023-04-20 23:15 | 1.8K | |
| Evenity (Generic Rom..> | 2023-04-20 23:15 | 8.6K | |
| Evenity (Generic Rom..> | 2023-04-20 23:15 | 4.9K | |
| Evenity (Generic Rom..> | 2023-04-20 23:15 | 9.3K | |
| Evenity (Generic Rom..> | 2023-04-20 23:15 | 5.5K | |
| Evenity (Generic Rom..> | 2023-04-20 23:20 | 1.9K | |
| Evenity (Generic Rom..> | 2023-04-20 23:15 | 1.2K | |
| Evenity (Generic Rom..> | 2023-04-20 23:20 | 3.0K | |
| Evenity (Generic Rom..> | 2023-04-20 23:15 | 2.0K | |
| Evenity (Generic Rom..> | 2023-04-20 23:20 | 8.3K | |
| Evenity (Generic Rom..> | 2023-04-20 23:15 | 5.5K | |
| Evenity (Generic Rom..> | 2023-04-20 23:20 | 9.6K | |
| Evenity (Generic Rom..> | 2023-04-20 23:15 | 6.4K | |
| Evenity (Generic Rom..> | 2023-04-20 23:20 | 20K | |
| Evenity (Generic Rom..> | 2023-04-20 23:15 | 14K | |
| Evenity (Generic Rom..> | 2023-04-20 23:15 | 20K | |
| Evenity (Generic Rom..> | 2023-04-20 23:15 | 15K | |
| Evkeeza (Generic Evi..> | 2023-04-20 22:57 | 16K | |
| Evkeeza (Generic Evi..> | 2023-04-20 22:52 | 11K | |
| Evkeeza (Generic Evi..> | 2023-04-20 22:57 | 31K | |
| Evkeeza (Generic Evi..> | 2023-04-20 22:52 | 22K | |
| Evkeeza (Generic Evi..> | 2023-04-20 22:57 | 76K | |
| Evkeeza (Generic Evi..> | 2023-04-20 22:52 | 52K | |
| Evomela Injection (G..> | 2023-04-20 22:21 | 2.2K | |
| Evomela Injection (G..> | 2023-04-20 22:15 | 1.5K | |
| Evomela Injection (G..> | 2023-04-20 22:21 | 3.3K | |
| Evomela Injection (G..> | 2023-04-20 22:15 | 2.1K | |
| Evomela Injection (G..> | 2023-04-20 22:21 | 9.2K | |
| Evomela Injection (G..> | 2023-04-20 22:15 | 6.0K | |
| Evomela Injection (G..> | 2023-04-20 22:21 | 12K | |
| Evomela Injection (G..> | 2023-04-20 22:15 | 7.7K | |
| Evomela Injection (G..> | 2023-04-20 22:21 | 22K | |
| Evomela Injection (G..> | 2023-04-20 22:15 | 16K | |
| Evusheld (Generic Ti..> | 2023-04-20 05:58 | 2.4K | |
| Evusheld (Generic Ti..> | 2023-04-20 05:58 | 1.4K | |
| Evusheld (Generic Ti..> | 2023-04-20 05:58 | 3.9K | |
| Evusheld (Generic Ti..> | 2023-04-20 05:58 | 2.3K | |
| Evusheld (Generic Ti..> | 2023-04-20 05:58 | 12K | |
| Evusheld (Generic Ti..> | 2023-04-20 05:58 | 7.3K | |
| Evusheld (Generic Ti..> | 2023-04-20 05:58 | 14K | |
| Evusheld (Generic Ti..> | 2023-04-20 05:58 | 8.3K | |
| Evusheld (Generic Ti..> | 2023-04-20 06:04 | 2.7K | |
| Evusheld (Generic Ti..> | 2023-04-20 05:58 | 1.8K | |
| Evusheld (Generic Ti..> | 2023-04-20 06:04 | 4.1K | |
| Evusheld (Generic Ti..> | 2023-04-20 05:58 | 2.8K | |
| Evusheld (Generic Ti..> | 2023-04-20 06:04 | 13K | |
| Evusheld (Generic Ti..> | 2023-04-20 05:58 | 8.6K | |
| Evusheld (Generic Ti..> | 2023-04-20 06:04 | 15K | |
| Evusheld (Generic Ti..> | 2023-04-20 05:58 | 11K | |
| Evusheld (Generic Ti..> | 2023-04-20 06:04 | 32K | |
| Evusheld (Generic Ti..> | 2023-04-20 05:58 | 23K | |
| Evusheld (Generic Ti..> | 2023-04-20 05:58 | 32K | |
| Evusheld (Generic Ti..> | 2023-04-20 05:58 | 24K | |
| Exkivity (Generic Mo..> | 2023-04-20 05:41 | 5.3K | |
| Exkivity (Generic Mo..> | 2023-04-20 05:36 | 3.8K | |
| Exkivity (Generic Mo..> | 2023-04-20 05:41 | 11K | |
| Exkivity (Generic Mo..> | 2023-04-20 05:36 | 7.4K | |
| Exkivity (Generic Mo..> | 2023-04-20 05:41 | 30K | |
| Exkivity (Generic Mo..> | 2023-04-20 05:36 | 19K | |
| Exservan (Generic Ri..> | 2023-04-20 05:15 | 1.0K | |
| Exservan (Generic Ri..> | 2023-04-20 05:10 | 368 | |
| Exservan (Generic Ri..> | 2023-04-20 05:15 | 1.3K | |
| Exservan (Generic Ri..> | 2023-04-20 05:10 | 446 | |
| Exservan (Generic Ri..> | 2023-04-20 05:15 | 2.0K | |
| Exservan (Generic Ri..> | 2023-04-20 05:10 | 1.0K | |
| Eysuvis (Generic Lot..> | 2023-04-20 04:51 | 9.0K | |
| Eysuvis (Generic Lot..> | 2023-04-20 04:46 | 6.5K | |
| Eysuvis (Generic Lot..> | 2023-04-20 04:51 | 6.0K | |
| Eysuvis (Generic Lot..> | 2023-04-20 04:46 | 4.2K | |
| Eysuvis (Generic Lot..> | 2023-04-20 04:51 | 20K | |
| Eysuvis (Generic Lot..> | 2023-04-20 04:46 | 13K | |
| Eysuvis (Generic Lot..> | 2023-04-20 04:51 | 51K | |
| Eysuvis (Generic Lot..> | 2023-04-20 04:46 | 34K | |
| Eysuvis (Generic Lot..> | 2023-04-20 04:51 | 53K | |
| Eysuvis (Generic Lot..> | 2023-04-20 04:46 | 34K | |
| Ferrous Fumarate (Ge..> | 2023-04-28 22:16 | 2.2K | |
| Ferrous Fumarate (Ge..> | 2023-04-28 22:14 | 1.4K | |
| Ferrous Fumarate (Ge..> | 2023-04-28 22:16 | 2.7K | |
| Ferrous Fumarate (Ge..> | 2023-04-28 22:14 | 1.8K | |
| Ferrous Fumarate (Ge..> | 2023-04-28 22:16 | 6.7K | |
| Ferrous Fumarate (Ge..> | 2023-04-28 22:14 | 4.4K | |
| Ferrous Fumarate (Ge..> | 2023-04-28 22:16 | 7.9K | |
| Ferrous Fumarate (Ge..> | 2023-04-28 22:14 | 4.3K | |
| Ferrous Fumarate (Ge..> | 2023-04-28 22:16 | 17K | |
| Ferrous Fumarate (Ge..> | 2023-04-28 22:14 | 9.5K | |
| Ferrous Gluconate (G..> | 2023-04-28 22:16 | 2.1K | |
| Ferrous Gluconate (G..> | 2023-04-28 22:11 | 1.4K | |
| Ferrous Gluconate (G..> | 2023-04-28 22:16 | 3.8K | |
| Ferrous Gluconate (G..> | 2023-04-28 22:11 | 2.6K | |
| Ferrous Gluconate (G..> | 2023-04-28 22:16 | 11K | |
| Ferrous Gluconate (G..> | 2023-04-28 22:11 | 7.7K | |
| Ferrous Gluconate (G..> | 2023-04-28 22:16 | 25K | |
| Ferrous Gluconate (G..> | 2023-04-28 22:11 | 18K | |
| Furoscix (Furosemide..> | 2023-04-24 03:32 | 3.5K | |
| Furoscix (Furosemide..> | 2023-04-24 03:26 | 2.4K | |
| Furoscix (Furosemide..> | 2023-04-24 03:32 | 2.6K | |
| Furoscix (Furosemide..> | 2023-04-24 03:26 | 1.8K | |
| Furoscix (Furosemide..> | 2023-04-24 03:32 | 10K | |
| Furoscix (Furosemide..> | 2023-04-24 03:26 | 8.2K | |
|